Stress cardiomyopathy pathophysiology

Jump to navigation Jump to search

Stress cardiomyopathy Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stress Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Unstable angina/non ST elevation myocardial infarction in Stress (Takotsubo) Cardiomyopathy

Future or Investigational Therapies

Case Studies

Case #1

Stress cardiomyopathy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Stress cardiomyopathy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Stress cardiomyopathy pathophysiology

CDC on Stress cardiomyopathy pathophysiology

Stress cardiomyopathy pathophysiology in the news

Blogs on Stress cardiomyopathy pathophysiology

Directions to Hospitals Treating Stress cardiomyopathy

Risk calculators and risk factors for Stress cardiomyopathy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

The cause of stress cardiomyopathy is unknown. Several theories have been postulated to explain the pathophysiology behind it:

The etiology of stress cardiomyopathy appears to involve the response of the myocardium to a hyperadrenergic state. The syndrome is often preceded by significant emotional and physical stress. Serum catecholamines may be markedly elevated in patients with stress cardiomyopathy with levels greater than seen in patients with thrombotic ST elevation myocardial infarction or congestive heart failure, though this is not always present. Thus, it has been postulated that catecholamine excess contributes at least in part to the pathophysiology, and that catecholamines may cause direct myonecrosis.[1] It is thought that myocardial stunning seen in stress cardiomyopathy is largely mediated by the effects of epinephrine.[2]

This theory is not well accepted, as it has been noted that multi-vessel epicardial coronary artery vasospasm does not correlate with the areas of myocardium that are hypokinetic.

Gross Pathology

Microscopic Pathology

Associated Conditions

Many neurological and psychiatric conditions are associated with the development of stress cardiomyopathy. These include:[3]

References

  1. Wittstein IS, Thiemann DR, Lima JA; et al. (2005). "Neurohumoral features of myocardial stunning due to sudden emotional stress". N. Engl. J. Med. 352 (6): 539–48. doi:10.1056/NEJMoa043046. PMID 15703419.
  2. Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE (2008). "Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning". Nat Clin Pract Cardiovasc Med. 5 (1): 22–9. doi:10.1038/ncpcardio1066. PMID 18094670.
  3. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari T, Airaksinen KE, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF (2015). "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy". N. Engl. J. Med. 373 (10): 929–38. doi:10.1056/NEJMoa1406761. PMID 26332547.
  4. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD, Wijdicks EF (2006). "Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction". J. Neurosurg. 105 (2): 264–70. doi:10.3171/jns.2006.105.2.264. PMID 17219832.
  5. Le Ven F, Pennec PY, Timsit S, Blanc JJ (2011). "Takotsubo syndrome associated with seizures: an underestimated cause of sudden death in epilepsy?". Int. J. Cardiol. 146 (3): 475–9. doi:10.1016/j.ijcard.2010.12.028. PMID 21194774.
  6. Sharp RP, Welch EB (2011). "Takotsubo cardiomyopathy as a complication of electroconvulsive therapy". Ann Pharmacother. 45 (12): 1559–65. doi:10.1345/aph.1Q393. PMID 22116995.
  7. Riera M, Llompart-Pou JA, Carrillo A, Blanco C (2010). "Head injury and inverted Takotsubo cardiomyopathy". J Trauma. 68 (1): E13–5. doi:10.1097/TA.0b013e3181469d5b. PMID 19065115.
  8. Yoshimura S, Toyoda K, Ohara T, Nagasawa H, Ohtani N, Kuwashiro T, Naritomi H, Minematsu K (2008). "Takotsubo cardiomyopathy in acute ischemic stroke". Ann. Neurol. 64 (5): 547–54. doi:10.1002/ana.21459. PMID 18688801.
  9. Summers MR, Lennon RJ, Prasad A (2010). "Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors?". J. Am. Coll. Cardiol. 55 (7): 700–1. doi:10.1016/j.jacc.2009.10.031. PMID 20170799.

Template:WH Template:WS